The latest price target for Imax (NYSE:IMAX) was reported by JP Morgan on February 21, 2025. The analyst firm set a price target for $27.00 expecting IMAX to rise to within 12 months (a possible 3.21% upside). 47 analyst firms have reported ratings in the last year.

The latest analyst rating for Imax (NYSE:IMAX) was provided by JP Morgan, and Imax maintained their neutral rating.

There is no last upgrade for Imax

There is no last downgrade for Imax.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imax was filed on February 21, 2025 so you should expect the next rating to be made available sometime around February 21, 2026.

While ratings are subjective and will change, the latest Imax (IMAX) rating was a maintained with a price target of $25.00 to $27.00. The current price Imax (IMAX) is trading at is $26.16, which is within the analyst’s predicted range.